The FDA approval is based on results from a trial investigating the effects of once-a-week Ozempic injections on major kidney ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

According to Novo Nordisk, over 40% of persons with type 2 diabetes have chronic renal disease, which affects roughly 37 ...

In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

Too much of a good thing is a bad thing, and a patient at Tampa General Hospital found that out the hard way when he ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks ...

An article published in JAMA Cardiology said a man in his 40s had been suffering from “yellowish nodules” on his palms, soles ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.